Product Images Ozempic
View Photos of Packaging, Labels & Appearance
- export 00
- Structural Formula - image 01
- Figure 1 - image 02
- Figure 2 - image 03
- Figure 3 - image 04
- Figure 4 - image 05
- Figure 5 - image 06
- Warning 1 - image 07
- Device 1 - image 08
- A - image 09
- B - image 10
- Flow_Symbol - image 100
- Symbol - image 101
- 4 mg/3 mL Carton - 8-9514-31-301-1 - image 102
- image 103
- image 104
- image 105
- image 106
- image 107
- image 108
- image 109
- C - image 11
- image 110
- image 111
- image 112
- image 113
- image 114
- image 115
- image 116
- image 117
- image 118
- image 119
- D - image 12
- image 120
- image 121
- image 122
- image 123
- image 124
- image 125
- image 126
- image 127
- image 128
- image 129
- E - image 13
- image 130
- image 131
- image 133
- F - image 14
- Warning 2 - image 15
- Dose 1 - image 16
- G - image 17
- H - image 18
- Warning 3 - image 19
- Dash 1 - image 20
- I - image 21
- Warning 4 - image 22
- J - image 23
- K - image 24
- L - image 25
- M - image 26
- N - image 27
- O - image 28
- Warning 5 - image 29
- P - image 30
- Q - image 31
- R - image 32
- S - image 33
- Warning 6 - image 34
- Warning 7 - image 35
- QR1 - image 36
- Bull 1 - image 37
- Warning 8 - image 38
- Device 2 - image 39
- a - image 40
- b - image 41
- c - image 42
- d - image 43
- e - image 44
- f - image 45
- Warning 9 - image 46
- Dose 2 - image 47
- g - image 48
- h - image 49
- Warning 10 - image 50
- Dash 2 - image 51
- i - image 52
- Warning 11 - image 53
- j - image 54
- k - image 55
- l - image 56
- m - image 57
- n - image 58
- o - image 59
- Warning 12 - image 60
- p - image 61
- q - image 62
- r - image 63
- s - image 64
- Warning 13 - image 65
- Warning 14 - image 66
Product Label Images
The following 100 images provide visual information about the product associated with Ozempic NDC 0169-4181 by Novo Nordisk, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 3 - image 04

This text presents information on the exposure levels (Cavg) of Semaglutide, a drug used in the treatment of diabetes, in relation to various demographic and clinical factors such as sex, race, ethnicity, body weight, and renal function. The data includes a comparison of Semaglutide exposure levels with a reference subject profile, along with confidence intervals. There is also information on the use of population PK models that take into account maintenance dose and injection site as covariates.*
Device 1 - image 08

OZEMPIC* pen and NovoFine® Plus needle are products likely used for medication injections. OZEMPIC* pen may be a brand name for an injection device, while NovoFine® Plus needle could be a type of needle designed for a specific use with the pen. Further information is needed to determine the exact purpose and function of these products.*
image 104

The text describes the OZEMPIC pen and NovoFine Plus needle. It shows the outer look of the pen, the cap of both the pen and the needle, the pen window, and the location of the expiration date. This information can be useful for someone who needs to learn how to use the OZEMPIC pen and needs to recognize it when they see it.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.